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ABSTRACT We outline a theoretical treatment that describes ﬁbril formation in dilute protein solutions. For this, we combine a
theory describing self-assembly and conformational transition with a description of the lateral association of linear chains. Our
statistical-mechanical model is able to predict the mean degree of polymerization and the length of the ﬁbrils and their precursors,
as well as the weight fractions of the different aggregated species in solution. We ﬁnd that there appear to exist two regimes as a
function of concentration, and as a function of the free energies of protein association: one in which low-molecular weight com-
poundsdominate andone inwhich theﬁbrils do. The transitionbetween these regimescanbequite sharp, andbecomessharper as
more ﬁlaments are allowed to associate into a single ﬁbril. The fraction of ﬁbrils consisting of less than the maximum allowed
number of ﬁlaments turns out to be negligible, in agreement with experimental studies, where the ﬁbril thickness is found to be
practically monodisperse. In addition, we ﬁnd that the description of the ﬁbril ends has a large effect on the predicted ﬁbril length.
INTRODUCTION
The self-assembly of naturally occurring, water-soluble pro-
tein molecules into ﬁbrous material (amyloid ﬁbril formation)
and the subsequent precipitation of these ﬁbrils are common
elements in a host of diseases. Prime examples include
Alzheimer’s and Parkinson’s diseases and prion-related
disorders (1–10). Besides the impact that this type of bio-
molecular self-assembly has on issues in disease study and
prevention, the ﬁeld has recently experienced a surge in
interest from the area of materials science (11–13). This is
because the properties of the assemblies are potentially ad-
justable by changing environmental factors such as pH or
temperature, the range of structures they can form is very
large, and their biological origin may allow their use in living
organisms. To better understand the mechanisms behind the
ﬁbrillogenesis, many experimental (5,10,14–21) and compu-
tational studies (6,8,22,23) have been performed recently.
Amyloidosis is a phenomenon observed in many proteins
under different conditions, seemingly independent of the
exact composition of the protein molecules (1,2,4,16,24).
Hence, it seems plausible that a general mechanism controls
the ﬁbril formation. We therefore propose a general theoret-
ical treatment for this ﬁbrillogenesis, valid for dilute solutions
(i.e., we assume that the ﬁbrils and their precursors do not
interact appreciably with each other). By focusing on the
common features of the ﬁbril formation, we necessarily ne-
glect many of the structural details of speciﬁc amyloid ﬁbrils.
These may differ from protein to protein (23). If one wishes to
give a more detailed description of the ﬁbril structure for a
speciﬁc protein, however, such details may easily be incor-
porated into the theoretical framework presented here.
Our treatment is not the ﬁrst theoretical study of protein
ﬁbrillogenesis. Earlier studies include the Oosawa-Kasai
model (25–27) and the more recent model of Nyrkova and
co-workers (11). Our model is a combination and an ex-
tension of these two theories. Speciﬁcally, we apply a recent
extension (beyond the all-or-nothing case) of the Oosawa
theory of two-state, linear assembly into ﬁlaments (26–29).
We then combine this approach with the description of lateral
assembly of ﬁlaments as applied by Nyrkova et al. (11). This
yields a quasi-one-dimensional model that can be resolved
analytically and that gives results that are exact within the
model assumptions.
The remainder of this article is organized as follows. In the
Theory section, we outline our model and present the equa-
tions that describe the ﬁbril formation. We also introduce
three sets of boundary conditions describing the ﬁbril ends,
and go on to show in Results that the choice of boundary
conditions has a potentially large effect on the predicted ﬁbril
properties. In this section, we also discuss our prediction of
the mean ﬁbril length, the fraction of protein molecules
present as monomers, dimers, ﬁlaments, and ﬁbrils, and the
fraction of proteins in a b-strand conformation, as a function
of the protein concentration and the free energies of inter-
action.We ﬁnd that there is a sharp transition between a ﬁbril-
dominated regime at high concentration and a regime
dominated by monomers and small aggregates at low con-
centration. Similar results are obtained as a function of the
various binding free energies. Finally,we give our conclusions
and outlook in the last section, remarking on the applicability
of our model and the steps necessary to present a comparison
between the theory and experimental results.
THEORY
To write down a theory for amyloid ﬁbril formation in dilute solution, we
must take the following general characteristics account. Firstly, it is known
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that the ﬁbrils have a well-deﬁned diameter and that they consist of several
intertwined ﬁlaments (4,8,24): for the 42-residue Ab peptide (a protein
linked to Alzheimer’s disease), e.g., the ﬁbrils are believed to be made up of
ﬁve or six ﬁlaments (3,8,20). Inside the ﬁbrils, protein molecules possess
a b-strand conformation, which allows them to form long intermolecular
b-sheets (known as cross-b-sheets). Secondly, so-called protoﬁbrils and
protoﬁlaments are known to play a role in the amyloidosis. The former
species is deﬁned as a semiﬁbrillar aggregate that plays a role early in the
amyloid ﬁbril formation, whereas the latter is a component of the mature
ﬁbrils, i.e., an amyloid ﬁbril is believed to be composed of several
protoﬁlaments (4,20,24). Finally, it is well established that nucleation is an
important factor in ﬁbrillogenesis (1,4,17,26,30,31). (We assume here that
the formation of protoﬁbrils and protoﬁlaments is a reversible process. This
need not be so for all proteins. The consequences of this are discussed in
Conclusions and Outlook. In classical nucleation and growth, an unstable
intermediate (the nucleus) plays an important role. Our treatment is unsuited
to describe the dynamics of this process, but we can describe the resulting
stable ﬁbrils. This, too, is discussed in Conclusions and Outlook.)
We outline below a model that combines these characteristics, shown in
Fig. 1. Here, blobs represent monomers in a disordered conformation, and
disks represent proteins in a b-strand-type conformation. The disk
representation was chosen for convenience, and is not meant to imply that
these molecules possess a cylindrical symmetry. We regard the monomeric
protein molecules as being in a disordered state, which we need not specify
further. These molecules can associate into dimers and ﬁlaments through a
relatively weak and reversible physical interaction. This association may be
due to, for instance, hydrophobic interactions, hydrogen bonding, electro-
static interactions, or a combination of such contributions. We presuppose
that two types of association can exist between protein molecules, one that
has a b-sheet-like character, and one that has a less ordered (non-b)
character. The former type of interaction is required because amyloid ﬁbrils
are known to possess a cross-b-sheet structure, as mentioned above, and we
include the latter type of interaction because it has been speculated that
(partially) disordered aggregates may form for some amyloid-forming
proteins (6,19,21,23). We assume that dimers contain only the latter,
relatively unfavorable, type of association. This ensures that b-type
associations (and the accompanying cross-b-sheets) only form in larger
aggregates. We make this assumption because cross-b-sheets are known to
only become stable if they contain a sufﬁcient number of monomers. In the
larger linear assemblies (the ﬁlaments), each monomer-monomer interaction
(except the ﬁlament ends, which shall be discussed in some detail below) can
have either a b-type character, if both molecules have a b-strand-type
conformation, or a disordered character, if this is not so.
Completing our description of the aggregated states, we describe the
ﬁbrils (which consist of several laterally associated ﬁlaments) as comprising
two parts: the ‘‘body’’, which we assume consists entirely of protein
molecules in a b-strand conformation (based on experimental evidence of
high b-sheet content in the ﬁbrils), and the ‘‘loose ends’’ or ‘‘legs’’ (11),
which make up the ends of the ﬁbrils, and which we treat as comprising
monomers in the disordered, non-b-state. This is discussed in more detail
below, in the Fibrils section. We furthermore assume that the ﬁlaments and
ﬁbrils are rigid structures, i.e., that they do not fold back upon themselves.
Note that in our description, ﬁlaments directly combine to form a ﬁbril,
without any intermediate steps. For many proteins, this process is somewhat
more complex, as the protoﬁlaments that combine to form the ﬁbril may
themselves consist of several intertwined ﬁlaments (24). However, there also
exist proteins for which the ﬁbril formation is believed to conform to our
description (24). With some slight adjustments, our theoretical framework
should be able to describe the more complex case as well.
The overall free energy per unit volume of a solution of self-assembling
material, DF, can be written as (11,33)
DF ¼ +
N
m¼1
rðmÞ½ln rðmÞ  1 lnQðmÞ1DFfibr: (1)
Here, DF is given in units of thermal energy, kBT, with kB Boltzmann’s
constant and T the absolute temperature. The same is true for all (free)
energies used throughout this article, unless explicitly noted otherwise. In
Eq. 1, r(m) is the dimensionless number density of (linear) aggregates of
degree of polymerization m, Q(m) is their (canonical) partition function, and
DFﬁbr is the free-energy term for ﬁbrils, to be detailed below in the Fibrils
section. From Eq. 1, we can calculate the equilibrium size distribution by
setting the functional derivative of the free energy with regards to the
number density r of any species (monomers, dimers, ﬁlaments, or ﬁbrils)
equal to zero, while enforcing conservation of mass. It turns out that the
equilibrium size distribution of each species equals its partition function,
multiplied by the exponent of mN, with N the number of protein molecules
that make up the aggregate and m a Lagrange parameter that we interpret as
the (dimensionless) chemical potential of the protein molecules. Now, to
establish the properties of the protein assemblies, we need to ﬁrst determine
the partition functions for the monomeric, dimeric, ﬁlament, and ﬁbril states.
Monomers and dimers
Because monomers are not involved in any associations, we set their
dimensionless Hamiltonian H(1) equal to zero, so that it acts as a reference
level. The partition function of the monomers, Q(1), is then equal to unity.
As mentioned above, we consider the dimers to consist of two disordered
molecules linked by a single interaction, with free energy M. The
Hamiltonian of a dimer is therefore H ¼ M, and its partition function
becomes Q(2) ¼ k [ exp M. Note that we ignore here any change of the
conformational state that may take place upon association, i.e., the difference
between the conformation of a protein molecule as a free monomer and the
same molecule bound in a dimer. This assumption avoids the introduction of
another free-energy parameter (as we shall discuss below, the problem at
hand already requires four such parameters) and is not too severe, because
the energy that accompanies this conformational transition only shifts the
binding energy by a ﬁxed amount (albeit, strictly speaking, only in the
inﬁnite-chain limit). Additionally, Nyrkova and co-workers show that, at
least for the DN1 protein they study (a protein that shows a similar ﬁbril
formation), the free energy of this conformational transition is signiﬁcantly
smaller than that of a monomer-monomer interaction (11).
Filaments
To describe the properties of the ﬁlaments, we apply a quasi-one-
dimensional two-state model (28). This model, which combines a model
for linear self-assembly (33) with one for a conformational transition
(34), was recently successfully applied in a description of the helical
FIGURE 1 Schematic representation of the aggregated
states. In the ﬁrst step monomers aggregate into ﬁlaments
with a variable b-sheet content (two examples are shown).
These ﬁlaments assemble into ﬁbrils in the second step
(two examples of ﬁbrils are shown, one containing six
ﬁlaments of equal length and one containing two ﬁlaments
of unequal length). Blobs indicate protein molecules in
a non-b-state, whereas disks represent proteins in a
b-conformation.
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self-assembly of disk-shaped molecules (28,35). We introduce two free-
energy parameters, in addition to the free energy for the formation of an
association between two monomers,M, given in the previous paragraph: the
excess free energy if both those monomers are in a b-strand conformation, P
(this measures the difference between the interaction in a cross-b-sheet with
free energy P* ¼ P1M and that in a disordered aggregate with free energy
M), and the free-energy penalty associated with a ‘‘frustrated’’ monomer,
i.e., a protein molecule that is bound to one of its neighbors with a b-type
association, and to the other with a non-b-type association, R (this can also
be seen as the free-energy penalty of an ‘‘interface’’ between a b-sheet
region and a disordered region along the aggregate axis). These free energies
are illustrated in Fig. 2 (also included here is the free energy F, needed to
describe ﬁbril formation. This parameter is described in the next subsection).
Note that the free energy of the conformational transition of a monomer
inside a ﬁlament, from a disordered state to a b-strand one, is not explicitly
taken into account here. Doing so would introduce another free-energy
parameter, which only renormalizes the parameters P and R.
We can now write down the dimensionless Hamiltonian Hﬁl needed to
describe ﬁlaments longer than two monomers. It equals (29)
Hfil ¼ 1
2
R +
m2
i¼1
ðsisi11  1Þ1 1
2
P +
m1
i¼1
ðsi1 1Þ1Mðm 1Þ;
(2)
where m gives again the number of protein molecules in the ﬁlament, and si
denotes the nature of each association; it has a value of unity if the
interaction is ordered in nature, (i.e., both monomers have a b-strand
conformation) and1 otherwise. The Hamiltonian Eq. 2 corresponds to that
of the Ising chain, with P corresponding to the magnetic-ﬁeld strength, si to
the spin value, and R to the spin-spin interaction.
To determine the partition function from the Hamiltonian, we apply the
well-known transfer matrix method (28,29,34,36). This means that we
deﬁne a matrix that gives the unnormalized probabilities (Boltzmann
weights) of each type of interaction, given the type of association that
precedes it. The method allows for a relatively easy way to calculate the
partition function via the eigenvalues of this matrix. The transfer matrix
takes the form
M ¼ ann anb
abn abb
 
: (3)
Here, ann gives the Boltzmann weight of a non-b-association (the
interaction that exists between two proteins that are not both in a b-strand
conformation) that follows a non-b-association, anb gives that of a non-
b-association after a b-association, abn that of a b-association after a non-
b-association, and abb that of a b-association after another b-association. If
we use the non-b bound state as the reference state and insert unity for a non-
b-association, s [ exp P for a b-interaction, and s1=2 ¼ exp R for a
monomer that is bound in a non-b way on one side, and in a b-way on the
other, we obtain (28,34,35)
M ¼ 1 s
1=2
ss
1=2
s
 
: (4)
The partition function of a ﬁlament with degree of polymerization m
is now given by
QðmÞ ¼ u Mm2  u1 : (5)
Here, the vectors u and u1 describe the ends of the ﬁlaments,
u ¼ un ubð Þ (6)
u1 ¼ u9n
u9b
 
; (7)
with un the unnormalized probability for the last protein-protein interaction
of the ﬁlament to have a non-b-character, u9n the Boltzmann weight for the
ﬁrst such interaction of the aggregate to be in a non-b-state, and ub and u9b
the same for the b-state. The evaluation of Eq. 5 is simpliﬁed if we
diagonalize the transfer matrix, M ¼ T L  T1, with L the diagonalized
matrix containing the eigenvalues of M, T the matrix of column eigen-
vectors
T ¼ s
1=2
s
1=2
l1  1 l2  1
 
; (8)
and T1 its inverse (35). The eigenvalues of M equal l1;2 ¼ 1=21
s=26ð1 2s1s214ssÞ1=2=2, where the 1 symbol gives l1 and the 
symbol l2 (27,33,34).
Now we need to specify the vectors that describe the ﬁlament ends. We
can impose one of three sets of boundary conditions (see van Gestel et al.
(29) for a detailed description). In the ﬁrst, we allow the ﬁrst and last
interactions of each ﬁlament to have a non-b or a b-character. The vectors u
and u1 then become (1 1) and (1 s)1. In the second, we constrain these
associations to be of the non-b-type. This means that we set ub and u9b equal
to zero, so that the vectors become (1 0) and (1 0)1. Similarly, we can ﬁx the
ends to be in a b-type conformation, with vectors (0 1) and (0 s)1.
That the choice of boundary conditions affects the conformational state
and mean length of helical self-assembled chains, has been described in
recent work (29). In this work, we set the ﬁrst and last monomer of the ﬁla-
ments to be in a non-b-state, an end description that corresponds to setting s1
and sm-1 both equal to 1 in Eq. 2. Our reason for doing so is, as mentioned
above, that this choice enables us to take into account the circumstance that
cross-b-sheets are only stable if they contain a large enough number of
molecules. Employing Eq. 5 to calculate the partition function, we obtain
FIGURE 2 Schematic depiction of the free-energy pa-
rameters applied in our model. M is the (reference)
association energy, P* ¼ P 1 M is the free energy for
the interaction between two monomers in a b-strand
conformation, R is the free-energy penalty on the forma-
tion of an ‘‘interface’’ between an ordered and a disordered
region, and F is the lateral interaction free energy.
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QðmÞ ¼ ðxlm21 1 ylm22 Þkm1: (9)
In Eq. 9, k is again the Boltzmann factor of a disordered-type interaction,
and x and y are prefactors dependent on the boundary conditions; for
the end description we apply, they equal x ¼ ðl1  sÞ=ðl1  l2Þ and
y ¼ ðs l2Þ=ðl1  l2Þ (29).
Fibrils
To describe the ﬁbrils, we include lateral interactions between the ﬁlaments.
This technique is known to provide a good description of the self-assembly
of the 11-residue DN1 polypeptide (11). In addition to the three free-energy
parameters described in the previous subsection, we now require a fourth
parameter, the free energy of a single lateral interaction, F, which describes
the strength of the interﬁlament associations inside a ﬁbril (see Fig. 2).
The Hamiltonian of a ﬁbril depends on the state of its ends, as does the
form of DFﬁbr in Eq. 1. In Nyrkova et al (11), the possibility is suggested that
the ﬁlaments that make up the ﬁbril need not have the same length, and
hence, the ﬁbril may have some ‘‘loose ends’’ or ‘‘legs’’. In our model, we
can also take these into account, and describe them as linear stretches of
proteins in a non-b conformation (case A). Earlier studies have led to
speculation that amyloid ﬁbrils, may, indeed, have partially unfolded ends.
(4) Alternatively, we can ﬁx the last monomer of the ﬁbrils to be in a
b-strand conformation, effectively deﬁning that the ﬁbrils comprise solely
proteins in a cross-b-sheet conformation (case B). It is also possible to allow
the ﬁbril ends to attain either of these states. In this latter case, which we
shall refer to as case C, we restrict the length of any ‘‘loose ends’’ to a single
monomer, for computational reasons. (We can also deﬁne a model in which
the loose ends can have any length from zero to inﬁnity by the application of
a Dirac d-function, which gives a value of unity if the length of a loose end
equals zero, and zero otherwise. However, we expect this to yield similar
results to the model C as deﬁned in the text, and this latter model is likely
easier to resolve analytically.) That this is reasonable follows from the work
of Nyrkova and co-workers, who ﬁnd that for realistic values of the free-
energy parameters, the mean length of the loose ends becomes less than a
single monomer (11).
The parameter DFﬁbr, giving the total free energy of ﬁbrils in dilute
solution, (see Eq. 1) equals DFA, DFB, or DFC depending on the boundary
conditions:
DFA ¼ +
N
n1¼1
   +
N
n2p¼1
+
p0
p¼2
+
N
m¼2
rðm; p; n1 . . . n2pÞ
3½ln rðm; p; n1 . . . n2pÞ1lnQðm; p; n1 . . . n2pÞ (10)
DFB ¼ +
p0
p¼2
+
N
m¼2
rðm; pÞ½ln rðm; pÞ  1 lnQðm; pÞ (11)
DFC ¼ +
1
q1¼0
   +
1
q2p¼0
+
p0
p¼2
+
N
m¼2
rðm; p; q1 . . . q2pÞ
3½ln rðm; p; q1 . . . q2pÞ1lnQðm; p; q1 . . . q2pÞ:(12)
Here, m is the number of protein molecules per ﬁlament that make up the
ﬁbril ‘‘body’’, p equals the number of ﬁlaments that comprise a ﬁbril, with
p0 its upper boundary enforced by the architecture of the ﬁbrils, ni. 0 gives
the number of monomers present in the ‘‘leg’’ numbered i, whereas qi gives
the same, however limited to a value of zero or unity. The Hamiltonians
for the three cases are as follows.
HA ¼ pðm 1ÞðM1PÞ1mðp 1ÞF1 2pR1 +
2p
i¼1
niM
(13)
HB ¼ pðm 1ÞðM1PÞ1mðp 1ÞF (14)
HC ¼ pðm 1ÞðM1PÞ1mðp 1ÞF1 +
2p
i¼1
qiðM1RÞ:
(15)
We obtain the following partition functions from the Hamiltonians Eqs.
13–15 for ﬁxed m, p, and ‘‘loose end’’ length.
QAðm; p; n1 . . . n2pÞ ¼ ðksf Þpm s
ks
 p
f
m
k
+
2p
i¼1
ni
(16)
QBðm; pÞ ¼ ðksf ÞpmðksÞpf m (17)
QCðm; p; q1 . . . q2pÞ ¼ ðksf ÞpmðksÞpf mðs1=2kÞ
+
2p
i¼1
qi
: (18)
In Eqs. 16–18, f [ exp F is the Boltzmann factor for lateral binding of
ﬁlaments; k gives again the Boltzmann factor for the formation of a non-b
association, and s that of the transition of a non-b-type interaction to a
b-type interaction, whereas s gives the square of the Boltzmann factor for an
interface between a non-b and a b-region along the ﬁbril axis, also as before.
Note that the ﬁbrils we discuss here are actually sheet-like in structure. To
describe proper ﬁbrils, the last ﬁlament would have to bind to the ﬁrst one,
closing the circle and thus forming a cylindrical aggregate. We may naively
include such a ﬁnal interﬁlament interaction in an easy way by setting the
lateral-binding term in the Hamiltonians Eqs. 13–15 equal to mpF. This,
however, is an approximation, as it implies that neither the difference in
entropy between a sheet and a cylindrical aggregate, nor elastic energies,
play a role in the ring closure. In the results section, we shall highlight the
differences between the sheet-like and the cylindrical conformations for
large ﬁbrils (p. 2), and show that this approximation is in fact a severe one.
Overall properties
Now that we have established the partition functions, we can calculate the
overall properties of a dilute solution of assembling protein molecules. Let
us ﬁrst focus on the overall size distribution r, obtained by adding the
number densities of monomers, dimers, ﬁlaments, and ﬁbrils. The number
densities of monomers and dimers are equal to rð1Þ ¼ zQð1Þ ¼ z and
rð2Þ ¼ z2Qð2Þ, with Q(1) and Q(2) given in the ‘‘Monomers and dimers’’
section, and with z [ exp m a fugacity. To determine the number density of
ﬁlaments, we need to perform a summation of rðmÞ ¼ zmQðmÞ over all
values of m. Because monomers and dimers are treated separately, we sum
from m ¼ 3 to m ¼ N. Similarly, we can determine the total number of
ﬁbrils per unit volume by summing over the relevant values of p, m, ni, and
qi, taking care to include a fugacity term for each of the protein molecules
present in the ﬁbrils. The limits of these summations are the same as those
seen in Eqs. 10–12. This gives for the overall size distribution
r ¼ z1 z2k1 xz
3
k
2
l1
1 zkl11
yz
3
k
2
l2
1 zkl21 +
p0
p¼2
rfibrilsðpÞ; (19)
with the ﬁbrillar terms given by
rAðpÞ ¼ f 2ðksfzÞ2p
s
ks
 p
kz
1 kz
 2p
1 ðksfzÞ
p
f
 1
(20)
rBðpÞ ¼ f 2ðf 2z2ksÞp 1
ðksfzÞp
f
 1
(21)
rCðpÞ ¼ f 2ðf 2z2ksÞp 1
ðksfzÞp
f
 1
ð11s1=2kzÞ2p: (22)
Here we have not yet evaluated the summation over p (see Eqs. 10–12),
because its upper bound depends on the protein being considered. For Ab1-42
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protein, e.g., as mentioned above, it is known that p0 most likely equals ﬁve
or six (3,8,20,31), but other values have been found for different proteins
(1,23). The reason why well-deﬁned ﬁbrils consisting of a ﬁxed number of
ﬁlaments are formed is unknown, but believed to be related to the
architecture of the ﬁbrils, most notably to the asymmetry of their building
blocks, and the inherent twist of the ﬁlaments.
Next, we calculate the total number of protein molecules per volume unit
in solution. This volume fraction f is given by the product of the number of
protein units in a given assembly and the dimensionless amount of that
particular assembly per unit volume, subsequently summed over all aggre-
gate sizes (28,29,35). It equals
f ¼ z1 2z2k1 xz
3
k
2
l1ð3 2zkl1Þ
ð1 zkl1Þ2
1
yz
3
k
2
l2ð3 2zkl2Þ
ð1 zkl2Þ2
1 +
p0
p¼2
ffibrilsðpÞ; (23)
with fﬁbrils given for the boundary conditions A, B, and C by
fAðpÞ ¼
pðsf 2z2ksÞp
f 2  f ðksfzÞp
kz
1 kz
 2p
2
1 kz1
2 ðksfzÞp=f
1 ðksfzÞp=f
 
(24)
fBðpÞ ¼ pf 2ðf 2z2ksÞp 2
ðksfzÞp
f
 
1 ðksfzÞ
p
f
 2
(25)
fCðpÞ ¼
pðf 2z2ksÞp
f
2  f ðksfzÞpð11s
1=2
kzÞ2p
3
2 ðksfzÞp=f
1 ðksfzÞp=f 1
2s
1=2
kz
ð11s1=2kzÞ
 !
: (26)
(Note that, in order for the volume fraction f to be ﬁnite, the com-
binations of parameters zkl1, zkl2 and (ksfz)
p/f must each have a value
smaller than unity.) Now, by dividing the volume fraction of monomers,
f(1)¼ z, by the total volume fraction, we can determine which mass fraction
of proteins is in the monomeric state. We can determine the mass fraction
of the other assemblies in the same way.
Another important quantity we can now determine is the mean degree
of polymerization. It is deﬁned as
ÆNæ[
f
r
: (27)
Complimentary to this overall mean aggregate size, we can ﬁnd the
mean degree of polymerization of ﬁlaments and ﬁbrils by dividing the
total number of protein molecules that make up the aggregates of that
type by the number of those aggregates. Their mean lengths can then be
found by dividing the mean degree of polymerization of the ﬁbrils by the
number of ﬁlaments they contain. By extension, this means that the mean
length of the ﬁlaments is equal to their degree of polymerization, and is
given by
ÆLæfil ¼ ÆNæfil ¼
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whereas that of the ﬁbrils becomes
ÆLæA ¼
ÆNæAðpÞ
p
¼ 2
1 kz1
2 ðksfzÞp=f
1 ðksfzÞp=f (29)
ÆLæB ¼
ÆNæBðpÞ
p
¼ 2 ðksfzÞ
p
=f
1 ðksfzÞp=f (30)
ÆLæC ¼
ÆNæCðpÞ
p
¼ 2 ðksfzÞ
p
=f
1 ðksfzÞp=f 1
2s
1=2kz
ð11s1=2kzÞ: (31)
Finally, we can use standard statistical-mechanical techniques to deter-
mine the mean fraction of monomers in a b-strand conformation, averaged
over all aggregate sizes and conformations. It is given by (for case A)
Here, the terms for monomers and dimers are omitted, because these
species cannot contain any b-type associations in our model. For case C, the
summations over ni would be replaced by those over qi, running from zero to
unity, whereas for case B the dependence on ni, as well as the corresponding
summations, would be absent. In Eq. 32, u is the fraction of b-type
interactions in a single ﬁlament or ﬁbril. For the ﬁlaments it is given by
uðmÞ ¼ ðm 1Þ1@ lnQðmÞ
@ ln s
¼ ðm 1Þ1 s
QðmÞ
@QðmÞ
@s
:
(33)
This can be understood if one realizes that the derivative after the ﬁrst
equal sign corresponds to the number of times the free energy of a b-type
interaction occurs in the total free energy of the ﬁlament. This equals the
number of interactions that have a b-character. The fraction of these
associations is then obtained by division by the total number of interactions,
m  1.
For a ﬁbril, u depends on the boundary conditions. It can readily be
determined by counting the number of interactions along the ﬁbril axis in the
‘‘body’’ of the ﬁbril (because these are deﬁned to have a b-character), and
dividing this number by the total number of associations, i.e., it equals
pðm 1Þ=½pðm 1Þ1+2p
i¼1 ni for case A, unity for case B, and pðm 1Þ
=½pðm 1Þ1+2p
i¼1 qi for case C.
Even without a numerical analysis of our model, we can already predict
the roles of the free-energy parameters and the way they interact. For the
reference interaction free energy, we know that a high value (a low value
of k) serves to inhibit intermonomer association, causing monomers to
dominate. For high values of k, on the other hand, assembly takes place. We
focus here on the latter, more interesting case, and look at two regimes, one
where the Boltzmann weight of the lateral-binding free energy, f, is very
small, and one where it is not.
In the former regime, a small value of s results in the formation of
monomers, dimers, and non-b-type ﬁlaments as the dominant species.
Conversely, large values of s favor the formation of ﬁlaments with a high
b-sheet content. The role of the parameter s, connected to the formation of
interfaces between ordered and disordered regions along the chain, now
Æuæ ¼
+
N
m¼3
mrðmÞuðmÞ1 +
N
n1¼1
   +
N
n2p¼1
+
p0
p¼2
+
N
m¼2
ðmp1 +
2p
i¼1
niÞrðp;m; n1 . . . n2pÞuðp;m; n1 . . . n2pÞ
f rð1Þ : (32)
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depends on the boundary conditions. If the boundary conditions prescribe
disordered ends and s is small, or if the boundary conditions prescribe
ordered ends and s is large, the value of s has little effect, as few interfaces
shall form. However, if the boundary conditions prescribe a state that is
unfavorable, given the value of s, then interfaces must form in any long
ﬁlaments or ﬁbrils. If such interfaces carry a large free-energy penalty (i.e.,
for small values of s), the aggregates tend to become very long to minimize
the number of interfaces by minimizing the number of ﬁlaments (28,29,35).
For high values of s, on the other hand, there is little effect.
For high values of f, we expect the ﬁbrillar state to dominate, especially if
s is also high. The parameters f and s (and k) are coupled, because each
increase in length of the ﬁbrils involves the formation of associations both in
the lateral and in the axial direction of the ﬁbril. The importance of the
parameter s depends again on which boundary conditions we impose. In
cases B and C, we expect its value to play a small role for high values of s; in
case A, however, we again predict a strong increase in the mean ﬁbril length
for small values of s, for the same reasons as those given above for
ﬁlaments.
We determine the overall properties of the solution of assembling protein
molecules by solving z from Eq. 23, for given values of s, f, k, p, s, and f,
and subsequently inserting the value of z into Eqs. 19, 27, and 32. Because
Eq. 23 is a higher-order equation in z, however, we obtain several possible
values for z as solutions. As it turns out, in all investigated cases, only one
of the solutions is physically relevant. Because z is deﬁned as being an
exponential, we can immediately discard any solutions below zero, as well
as any imaginary ones. We can test the remaining solutions by inserting
them into the equations and calculating the mean lengths and fractions of
each aggregated state. For all but one solution, this leads to physically
unrealistic values for at least one of these quantities (such as a negative
volume fraction, or an aggregate length below unity). The remaining so-
lution is the one we apply (this turns out, in all cases investigated, to be the
solution with the lowest value, larger than zero). In the next section, we show
our results for different values of the free-energy parameters, for different
boundary conditions, and for ﬁbrils containing different numbers of ﬁla-
ments. We focus on the mean degree of polymerization, the mean ﬁbril
length, and the weight fractions of the various assembled species.
RESULTS
Boundary conditions
As discussed in the previous section, it is necessary in our
model to deﬁne a conformation for the ends of the ﬁlaments
that comprise the ﬁbril. The effect of a change in the de-
scription of these ends can be seen in Fig. 3, for the casewhere
we only allow ﬁbrils consisting of two ﬁlaments. The mean
length of the ﬁbrils is strongly affected by our choice of
boundary condition, a result that was also found for aggre-
gates that form by linear self-assembly with a helical transition
(29). In amyloid ﬁbrils, for the same values of the free-energy
parameters, we observe a much stronger increase in the mean
size for the case where each ﬁbril can only have non-b ends
than for the other two cases. This is due to the presence of
penalized ‘‘interfaces’’ betweenb-regions and non-b-regions
at each of the ﬁbril ends. Because these interfaces are un-
favorable, the system strives to minimize their number by
allowing fewer (and hence longer) aggregates to form. For the
case of thicker ﬁbrils (containing 2–6ﬁlaments), the trends are
quite similar (results not shown).
In the following we shall determine the impact of the
various free-energy parameters, and of the overall protein
concentration. First we brieﬂy summarize results of the case
where no ﬁbril formation occurs and only monomers, di-
mers, and ﬁlaments are allowed. We then show the case
where the only ﬁbrils allowed are those containing two ﬁla-
ments (p ¼ 2). This allows for faster calculations than the
case where we allow thicker ﬁbrils, and, as we shall show
below, the trends are similar to that case. After this we dis-
cuss the more general case where ﬁbrils of two, three, four,
ﬁve, or six ﬁlaments are considered (p ¼ 2–6).
The case where no ﬁbrils form
This case corresponds to a description of linear self-assembly
with a conformational transition. Our model to describe this
is identical to a recent model for helical self-assembly, and
hence our results are also identical (with the b-strand state in
this article corresponding to the helical one in earlier works).
A full discussion is beyond the scope of this article, and we
refer to the earlier work (28,29,35). Summarizing, it was
found that the conformational transition can be quite sharp
and that it couples to the mean size of the aggregates,
resulting in a strong increase in their average degree of
polymerization that sets in near the point where the helical
conformation becomes dominant.
The case p 5 2
Let us now examine the case where the only ﬁbrils that are
present consist of two ﬁlaments. To study the properties of a
solution of this type, we solve Eq. 23 for ﬁxed p ¼ 2,
removing the summation in this equation. In the following
we focus on the boundary conditions set C (ends are not
FIGURE 3 Mean length of ﬁbrils consisting of two ﬁlaments as a function
of concentration, for s[ exp P ¼ 70, k[ exp M ¼ 50, s [ exp 2R ¼
0.1, and f [ exp F ¼ 3, and three boundary conditions, as indicated. Case
A corresponds to a description in which all ﬁbril ends are ﬁxed to be dis-
ordered, case B is that in which they are restricted to a b-strand confor-
mation, and in case C the ends are unrestricted.
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restricted), but we shall highlight signiﬁcant differences be-
tween the results for different boundary conditions through-
out the section. We choose end description C because we
(and others) speculate that the ﬁbril ends may have a non-b
conformation (4), due to the greater conﬁgurational freedom
this would allow for these ends. We eliminate case A (which
restricts the ends to a non-b conformation) because this leads
to extremely large ﬁbril lengths, as seen in Fig. 3. It is, how-
ever, not unthinkable that there exist proteins for which the
boundary condition A is appropriate.
In Fig. 3, we see that the ﬁbrils are very short at low
concentrations, and that they exhibit a strong increase in
length at a critical volume fraction of protein molecules (in
this case, approximately f ¼ 2 3 104). (The molar con-
centration can be determined from the volume fraction f by
dividing the volume fraction by the molecular volume of the
protein.) At higher concentrations, the dependence of the
mean ﬁbril length (plotted logarithmically) on the logarithm
of the volume fraction is linear with a slope of one-half,
indicating that, at these concentrations, the mean length of the
ﬁbrils scales with the square root of f. This is the same
dependence that is encountered in self-assembled chains
(33,35). In this ﬁgure and all following ones, we have used for
the free-energy parameters values between zero and a few
times the thermal energy. Although we do not know exact
values for the binding energies between proteins, we estimate
that the values we use here are reasonable for monomers that
are bonded through nonpermanent, physical interactions. We
vary these parameters somewhat between ﬁgures, to empha-
size the salient features of the ﬁbril formation.
Like the mean size of the ﬁbrils, the composition of the
solution also shows a strong dependence on the protein con-
centration. This is shown in Fig. 4, where we plot the weight
fraction of each aggregated species as a function of the
volume fraction of protein molecules. As mentioned above,
the weight fractions are given by the volume fraction of
protein molecules present in a certain state (e.g., monomeric
or ﬁbrillar), divided by the total volume fraction of protein
molecules, f. So, for instance, the weight fraction of ﬁbrils is
found by dividing Eqs. 26 and 23, for p ¼ 2. The results
show that there is a transition between a regime where
monomers dominate (at low volume fraction), and one where
ﬁbrils dominate, at high volume fraction. (This is true for all
three boundary conditions.) This transition can be quite
sharp, dependent on the values we choose for the free-energy
parameters. The dimers and ﬁlaments that are present at low
concentrations, are repressed past the transition point, where
ﬁbrils dominate. Although it is not immediately clear from
this ﬁgure, for most of the investigated parameter values,
monomers are actually the most abundant species, even at
high volume fractions. However, because ﬁbrils can become
quite long, the weight fraction of the monomers tends to
become negligible when ﬁbrils emerge.
The dependence of theweight fractions onf, seen in Fig. 4,
is reproduced almost exactly in their dependence on the
(reference) free energy of a monomer-monomer interaction
M, albeit mirrored, as shown in the inset to Fig. 4. This implies
that, in the context of ourmodel, the same change in properties
may be achieved by a change in the concentration or by a
change in the solvent conditions leading to a shift in M.
The mean fraction of material in a b-strand conformation
(not shown) is predictably small at low volume fractions
(because monomers and dimers, which are deﬁned as dis-
ordered, dominate here) and undergoes a sharp transition at
the critical concentration to reach values close to unity,
following the curve for the weight fraction of ﬁbrils almost
exactly (as would be expected for boundary conditions B,
where ﬁbrils contain no disordered interactions). This indi-
cates that any disordered ends in the ﬁbrillar state play a small
role, either due to the large ﬁbril length or to the circumstance
that their presence requires an unfavorable interface to be
formed. For values of the free-energy parameters that allow
the ﬁlament state to play a more prominent role (such as
unfavorable values of F) the curve may deviate from the ﬁbril
fraction curve, but we still expect a rather sharp transition, the
sharper the larger R (28,29,34,35).
The effect of a change in the excess b-association energy,
P, can be seen in Fig. 5. Here, too, there are two regimes, one
in which ﬁbrils dominate and one in which this is not so. For
the same values of the free-energy parameters R and F and
the concentration as in the inset to Fig. 4, we ﬁnd that a
decrease of 5 kBT in P sufﬁces to go from a weight fraction of
ﬁbrils of approximately zero to one of almost unity. The
same is observed in the inset to Fig. 4, for the reference as-
sociation free energy,M. In fact, the main difference between
the insets to Figs. 4 and 5 is the composition of the solution
at high values of the free energy. In Fig. 4, monomers
dominate, whereas here, there is a signiﬁcant (and constant)
FIGURE 4 Weight fraction of monomers, dimers, ﬁlaments, and ﬁbrils
(containing two ﬁlaments) in solution, as indicated, as a function of con-
centration, for s ¼ 10, k ¼ 250, s ¼ 0.1, and f ¼ 2. (Inset) Same as Fig. 4,
but as a function of reference association free energy M, at volume
fraction f ¼ 103.
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fraction of ﬁlaments and dimers present, even at P ¼ 0. This
is because, in our model, dimers are deﬁned as disordered
(and hence, their fraction is unaffected by the value of P, but
affected by that of the reference association free energy M),
and ﬁlaments are also likely in a non-b conformation, unless
the ‘‘frustrated monomer’’ free energy R is small. This
means that the fractions of dimers and disordered ﬁlaments
do not directly depend on the value of P, whereas they must
go to zero for high values of M.
The effect of P on the length of the ﬁbrils, as well as on the
overall mean aggregate size (Eq. 27) is shown in the inset to
Fig. 5. Here, again, we see the presence of a critical value,
above which the increase of the mean aggregate size is slow,
and below which the curves are linear. This time the slope of
the linear portion of the ﬁbril-length curve equals unity, rather
than one-half as was the case with the concentration de-
pendence. We also ﬁnd that the (free) ﬁlaments stay short,
regardless of the value of P (not shown). For the cases A and
B the trends are the same as in case C, although for case A,
the ﬁbril length is much larger than for cases B and Cwhereas
the weight fraction remains the same; see also Fig. 3.
The value of the interface penalty R has no effect on the
mean size and solution composition for cases B and C. This
is not so for case A, which shows a great increase of the ﬁbril
length with increasing R (results not shown). Because in
cases B and C the presence of interfaces within the ﬁbrils is
either impossible or unlikely for the values of the other
energetic parameters used here, the free-energy penalty is not
often invoked, and hence has little to no effect. For case A,
which is deﬁned as having an interface at every ﬁlament end
within the ﬁbril, an unfavorable (i.e., large) value of R causes
the number of ﬁbrils to decrease, which in turn causes a
strong increase in their length. The value of R is known to
have a strong effect on the length and conformational state
of the ﬁlaments as well, and hence we can expect to see the
inﬂuence of a change in R, even in cases B and C, under
circumstances where the ﬁlament state dominates (28,34,35).
That the effect of a change in the lateral interﬁlament
binding free energy, F, can be quite drastic (see Fig. 6) is not
surprising, given that the linking of two ﬁlaments involves a
free energy equal to mF with m the length of the ﬁlaments. A
small change in F then leads to a large change in this free
energy. Hence, the system displays a preference for long
ﬁbrils for F , 0, expressed by a strong increase of the
ﬁbrillization. Nevertheless, we see that the change from a
regime where there are hardly any ﬁbrils to one where their
weight fraction is almost unity, again requires a change in the
relevant free-energy parameter of ;5 kBT. Filaments, which
are the dominant species for high values of F for this set of
free-energy parameters, show a very rapid decline as ﬁbrils
become dominant. This decrease is also evident in the mean
length of the ﬁlaments, as shown in the inset to Fig. 6.
Contrary to the concentration and the free-energy parameters
P and M, the value of F has a relatively modest effect on the
mean ﬁbril length in the ﬁbril-rich regime. This is likely due
to the circumstance that elongation of (the body of) a ﬁbril
requires that at least two monomers become attached to it.
This implies an increase of the free energy of F1 2P1 2M.
Hence, the effect of a change in F on the length of the ﬁbrils
is smaller than those ofM and P. The overall mean degree of
polymerization, in any case, still shows the same trend as
before, a very slow increase, followed by a sudden increase,
and a linear dependence of the logarithm of the mean
aggregate size on F. The dependence on F follows the same
trends for boundary conditions A and B (not shown).
FIGURE 5 Weight fraction of monomers, dimers, ﬁlaments, and ﬁbrils
(containing two ﬁlaments) in solution, as indicated, as a function of excess
b-association energy P, for volume fraction f¼ 103, k¼ 250, s¼ 0.1, and
f ¼ 2. (Inset) Mean length of ﬁbrils consisting of two ﬁlaments as a function
of excess b-association energy P, for the same parameter values as in Fig. 5.
FIGURE 6 Weight fraction of monomers, dimers, ﬁlaments, and ﬁbrils
(containing two ﬁlaments) in solution, as indicated, as a function of lateral
association free energy F, for volume fraction f ¼ 103, k ¼ 250, s ¼ 0.1,
and s ¼ 10. (Inset) Mean length of ﬁbrils consisting of two ﬁlaments as a
function of lateral association free energy F, for the same parameter values
as in Fig. 6.
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The case p 5 2–6
Let us now generalize our description of ﬁbrils somewhat,
and allow ﬁbrils that consist of two, three, four, ﬁve, and six
ﬁlaments to form. For this, we set p0 ¼ 6 in Eqs. 19, 23, and
32. When we compare this to the case where only p ¼ 2 is
allowed (see Fig. 7), we see that the sixfold ﬁbrils tend to be
much longer than those in the earlier model, but that the
trends are the same. The same applies to the mean degree of
polymerization. It must be noted, however, that the slopes in
the ﬁbril-dominated regime are not all the same. The slope of
the curve describing ÆNæ changes from a value of 4/5 in the
case p ¼ 2 to a value of unity for the case p ¼ 2–6. This
increased dependence of the mean aggregation number on
the concentration must be due to lateral-association effects,
because the length of the chains does not show a similar
increase; the slopes for the mean length of the thickest ﬁbril
allowed both equal one-half.
Focusing on the dependence of the mean ﬁbril length on
the protein volume fraction, we notice that, although there is
a sizeable increase in the mean ﬁbril length for those ﬁbrils
that consist of six ﬁlaments, a similar increase is not seen for
ﬁbrils consisting of less than six ﬁlaments (the largest
increase is seen for p ¼ 5, and even this is almost negligible;
see Fig. 8). This corresponds to what is found experimen-
tally, where ﬁbrils are known to have a well-deﬁned, prac-
tically monodisperse, diameter (3). The small size of thinner
ﬁbrils is likely caused by the circumstance that a sixfold ﬁbril
contains m more interﬁlament contacts than a ﬁvefold one,
and hence beneﬁts more from a favorable value of F. Be-
cause this is so for any value of p in our model, we may
expect that the thickest allowed ﬁbril shall always dominate
over thinner ﬁbrils for favorable values of F. This does not
correspond to the observation of an optimum ﬁbril thickness
in experimental studies. To quantitatively take this into ac-
count, we have to include more detailed structural infor-
mation in our model (see also below). A study to this effect is
currently in progress.
Let us now examine the weight fraction of the aggregated
states as a function of protein volume fraction and M. Again
the two plots (Fig. 9 and its inset) look identical, albeit mir-
rored, and again we see that there are two regimes, one where
ﬁbrils dominate and one where they do not. (The fractions of
dimers, ﬁlaments, and ﬁbrils with p, 6 are indistinguishable
from zero in the plot and hence are omitted.) The transition is,
FIGURE 7 Mean length of ﬁbrils and mean degree of polymerization
as a function of the volume fraction of protein molecules, for s ¼ 15, k ¼ 8,
s ¼ 0.01, and f ¼ 45, and for ﬁbrils consisting of two ﬁlaments, and of two
to six ﬁlaments, as indicated.
FIGURE 8 Mean length of ﬁbrils consisting of ﬁve and six ﬁlaments and
overall mean degree of polymerization as a function of the protein volume
fraction, for s ¼ 15, k ¼ 8, s ¼ 0.01, and f ¼ 45.
FIGURE 9 Weight fraction of monomers and ﬁbrils (containing two to
six ﬁlaments) in solution, as indicated, as a function of protein volume
fraction, for s ¼ 15, k ¼ 8, s ¼ 0.01, and f ¼ 45. (Inset) Same as Fig. 9,
but as a function of association free energy M, at volume fraction
f ¼ 103.
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however, far less gradual than was the case for p¼ 2, and the
change in the slope of the curve is very sudden. This is
probably due to the cooperativity in the ﬁbril formation,
which is stronger for p¼ 6 than it is for p¼ 2, because many
more lateral associations are formed in the former case.
Similar sharp transitions were observed by Nyrkova and co-
workers in their model (11). This is not surprising because our
description of the ﬁbrils and theirs closely resemble each
other. (Due to the different deﬁnitions of the free-energy
parameters, a direct comparison of the model of Nyrkova
et al. (11) and our model is not possible. We may, however,
note that the trends, especially in the ﬁbril-dominated regime,
of our model and theirs, are similar.)
Contrary to our model, Nyrkova’s model presupposes a
b-sheet structure for all assemblies, with the exception of the
monomers. Note that in the limit where the (ordered) ﬁbrils
dominate, the fraction of any disordered assemblies is likely
very small; the Nyrkova model may provide a very good
description when this is the case. Therefore, it may be used
pragmatically even in cases where disordered aggregates are
known to form. The circumstance that the Nyrkova model
essentially uses three parameters, rather than our four, makes
it a very attractive model in this regard. Nonetheless, there
most likely exist ﬁbril-forming proteins that require disor-
dered protein aggregates to be taken into account explicitly.
Indeed, several studies have indicated that (partially) disor-
dered protein molecules may play an important role in the
ﬁbrillogenesis (4,6,19,21,23).
As already advertised in the Theory section, we now study
what the effect of the introduction of an extra parameter f is.
This extra parameter would serve to close the cylinder, so that
our description corresponds to a ﬁbrillar state, rather than a
sheet-like one. We treat the ﬁbrils with p ¼ 2 as having m
lateral interactions, whereas for the larger ﬁbrils we include an
extra contact to form the cylindrical ﬁbril. This relatively
small change causes a great shift in the size distribution, as the
ﬁbrils consisting of three ﬁlaments now dominate at high
concentrations, both in terms of length and of weight fraction.
This shift deserves further study. We speculate that the free
energy for ring closure must be unequal to F for systems
where thick ﬁbrils are known to dominate, as we argued
above. To take the ring closure effect into account in a proper
way, it may be necessary to include a p-dependent elastic term
in our description of the ﬁbril formation, and to explicitly take
into account factors like the architecture of the ﬁlaments
inside the ﬁbrils, their distribution of hydrophilic and
hydrophobic groups, and their helical twist. Some of these
effects have been taken into account in Nyrkova et al. (11,40).
This shall be explored in a separate publication, in which we
compare theory and experiment.
CONCLUSIONS AND OUTLOOK
We have outlined a theoretical treatment for self-assembly
with a conformational transition, coupled to the lateral
association of chains. Our theory, which is analytical and
exact within the model assumptions, mimics the general
properties of amyloid ﬁbril formation, in a more detailed
manner than has been attempted before. It predicts the mean
length of ﬁbrils and the fractions of each aggregated species
in dilute solution, as well as the fraction of protein molecules
in a b-strand conformation. We ﬁnd two regimes as a func-
tion of concentration and of the free energies of the various
types of association: one where ﬁbrils dominate and one
where low-molecular-weight species do. The transition be-
tween these regimes can be quite sharp because the ﬁbril
formation may be highly cooperative. We ﬁnd that the
formation of thick ﬁbrils is favored, and that the fraction
of ﬁbrils consisting of fewer than the maximum allowed
number of ﬁlaments is negligible. The mean ﬁbril length
increases slowly at low protein volume fraction, then dis-
plays a strong and sharp increase at a critical volume frac-
tion, and then shows a (weaker) exponential increase at
higher volume fractions. Similar trends are observed for the
mean ﬁbril length as a function of the various association
free energies. Finally, we ﬁnd that our description of the
ﬁbril ends can have a large effect on the properties of the
aggregates. This effect of boundary conditions seems to
indicate that if we can affect the state of the ﬁbril ends, it may
prove possible to inhibit the ﬁbril formation.
Our theory is potentially useful in describing the aggre-
gation behavior of any protein that self-assembles into
ﬁbrillar structures. Systems that form amyloid ﬁbrils in a way
that resembles that of Fig. 1 include certain prion proteins,
amyloid b-protein, b-lactoglobulin, t-protein, insulin,
b-microglobulin, a-synuclein, hen egg white lysozyme, and
light-chain immunoglobulin. Our model may therefore be
useful in their description (4,24,41–46). Although we have
focused in the above on amyloidosis, we speculate that the
different aggregated states of actin and tubulin (in the pres-
ence of abundant GTP) are also reminiscent of those we out-
line in Fig. 1 (26,27,47,48). In both cases, two conformations
are possible (in the case of actin, nonhelical and helical,
and in the case of tubulin the so-called straight conformation
and the bent one), and in both cases it seems that ﬁbrils can
be thought to consist of several laterally associated linear
chains.
Note that in the description outlined in the Theory section,
we assume that all the steps of the protein ﬁbril formation are
reversible. Although this is certainly so for certain proteins, it
need not be true for others. Indeed, it is believed that
transient species, i.e., thermodynamically unstable aggre-
gates that are rapidly and irreversibly converted into other
species, may play a role of some importance in amyloid ﬁbril
formation. An example of this type of aggregate is the
nucleus that forms and then grows into (the beginnings of) a
ﬁbril. Our theory, being statistical-mechanical in origin,
cannot in principle describe truly irreversible processes; to
provide an accurate description of transient species, a kinetic
model is required. Note, however, that by choosing proper
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values for the free-energy parameters, it is possible to shift
the equilibrium between two states to such a degree that the
less favorable state becomes negligibly populated.
Because the identity of the nucleus (its size and conforma-
tion) and any other unstable speciesmay differ from protein to
protein, we have not taken these into account in our general
treatment. If one wishes to apply our statistical-mechanical
treatment to an experimental system in which aggregates that
disappear from the solution in a truly irreversible fashion play
a role, one needs to carefully distinguish between the stable
states and the transient ones, and only take the former into
account. This ensures that the concentration of any unstable
intermediate equals zero in equilibrium, whereas stable struc-
tures are taken into account in a proper way.
To conclusively determine which systems can be described
by the theory as outlined in this article, a detailed comparison
between experiment and theory must be performed. This is
currently in progress, and shall be discussed in a separate
publication. Although the majority of experimental data on
amyloid ﬁbril formation is kinetic in nature (i.e., measured
as a function of time) there have been some studies of the
(equilibrium) ﬁbril length and ﬁbril fraction as a function
of concentration (14,17,19). The former type of informa-
tion may be found from radiation scattering experiments
(9,14,17,19,31), whereas the latter type can be obtained by
chromatography and sedimentation studies (17,31). There
have also been numerous studies that determine the b-sheet
content by measuring the ﬂuorescence of the ﬁbrils after
thioﬂavin-T or Congo red binding (18,30), but these tech-
niques seem to bemore qualitative than quantitative in nature,
as the binding between the dye and the amyloid ﬁbril is still
not completely understood. Alternative methods for measur-
ing the fraction of protein in any one conformation may also
prove useful in comparing theory and experiment; here one
can think of, e.g., circular dichroism spectroscopy (9,10). In
addition to concentration dependence, we may look at the
temperature dependence of the ﬁbril formation. Although a
recent article indicates that this effect is quite small (at large
timescales, when the solution has had time to equilibrate) for
Ab peptide (15), this need not be the case for other proteins.
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